CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Pharmaceutical Technology
High ImpactOriginal article

FDA approves Viatris’ Ryzumvi for adult presbyopia

RegulatoryapprovedRyzumviPositive
AI Analysis

Summary

The US FDA has approved Viatris' Ryzumvi (phentolamine ophthalmic solution 0.75%) for the treatment of presbyopia in adults.

Outcome Details

FDA approved Ryzumvi (phentolamine ophthalmic solution 0.75%) for the treatment of presbyopia in adults.

Importance:8/10
Sentiment:
0.60
FDA approvalpresbyopiaophthalmologyRyzumviphentolamine
Related Companies

Read the original article

Published by Pharmaceutical Technology on October 19, 2026 9:41 AM

Read Original